Use of umbilical cord and cord blood-derived stem cells for tissue repair and regeneration

Expert Opinion on Biological Therapy

Volumn 14, Issue 3, 2014, Pages 301-310

  Biazar, Esmaeil ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

in vivo; Stem cells; Tissue repair and regeneration; Umbilical cord

Indexed keywords

ADULT STEM CELL; ANIMAL; CELL DIFFERENTIATION; CORD BLOOD STEM CELL TRANSPLANTATION; FETUS BLOOD; HUMAN; PHYSIOLOGY; PROCEDURES; REGENERATION; TISSUE ENGINEERING; TRANSPLANTATION; TRENDS; UMBILICAL CORD; WOUND HEALING;

ADULT STEM CELLS; ANIMALS; CELL DIFFERENTIATION; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HUMANS; REGENERATION; TISSUE ENGINEERING; UMBILICAL CORD; WOUND HEALING;

EID: 84894193391     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2014.867943     Document Type: Review

References (98)

1. Karamichos D, Rich Celeste B, Hutcheon Audrey EK,et al. Self-assembled matrix by umbilical cord stem cells. J Funct Biomater 2011;2:213-29
2. Malgieri A, Eugeni K, Patrizi MP, Gambardella S. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med 2010;3(4):248-69
3. Sarugaser R, Lickorish D, Baksh D,et al. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005;23(2):220-9
4. Kluth SM, Radke TF, Kogler G. Potential application of cord bloodderived stromal cells in cellular therapy and regenerative medicine. J Blood Transfus 2012;2012:365182; 1-7
5. Ali H, Al-Mulla F. Defining umbilical cord blood stem cells. Stem Cell Dis 2012;2:15-23
6. Kumar A, Kumar P. Umbilical cord blood stem cell and its immunoregulatory properties initiative towards clinical application. J Med Res 2013;1(2):14-17
7. Liu G, Ye X, Zhu Y,et al. Osteogenic differentiation of GFP-labeled human umbilical cord blood derived mesenchymal stem cells af-ter cryopreservation. Cryobiology 2011;63:125-8
8. Xu ZF, Pan AZ, Yong F,et al. Human umbilical mesenchymal stem cell and its adipogenic differentiation: profiling by nuclear magnetic resonance spectroscopy. World J Stem Cells 2012;4:21-7
9. Chen X, Zhang F, He X,et al. Chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells in type I collagen-hydrogel for cartilage engineering. Injury 2013;44(4):540-9
10. Kocaefe C, Balci D, Hayta BB, Can A. Reprogramming of human umbilical cord stromal mesenchymal stem cells for myogenic differentiation and muscle repair. Stem Cell Rev 2010;6:512-22
11. Liu J, Xu Hockin HK, Zhou H,et al. Human umbilical cord stem cell encapsulation in novel macroporous and injectable fibrin for muscle tissue engineering. Acta Biomater 2013;9:4688-97
12. Khattab RAM, Khorshied MMA, Abdel Shafy SS,et al. In vitro transdifferentiation of umbilical cord stem cells into cardiac myocytes: role of growth factors for cardiac myocytes transdifferentiation. Egypt J Crit Care Med 2013; In press
13. Sellamuthu S, Manikandan R, Thiagarajan R,et al. In vitro transdifferentiation of human umbilical cord derived hematopoietic stem cells into hepatocyte like cells using combination of growth factors for cell based therapy. Cytotechnology 2011;63(3):259-68
14. Wang HS, Shyu JF, Shen WS,et al. Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat nod mice. Cell Transplant 2011;20:455-66
15. Cho H, Seo YK, Jeon S,et al. Neural differentiation of umbilical cord mesenchymal stem cells by sub-sonic vibration. Life Sci 2012;90:591-9
16. Kim DW, Staples M, Shinozuka K,et al. Whartons jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci 2013;14:11692-712
17. Lindenmair A, Hatlapatka T, Kollwig G,et al. Umbilical cord tissue and their potential for clinical applications. Cells 2012;1:1061-88
18. Diao Y, Ma Q, Cui F, Zhong Y. Human umbilical cord mesenchymal stem cells: osteogenesis in vivo as seed cells for bone tissue engineering. J Biomed Mater Res 2009;91:123-31
19. Jang BJ, Byeon YE, Lim JH,et al. Implantation of canine umbilical cord blood-derived mesenchymal stem cells mixed with beta-tricalcium phosphate enhances osteogenesis in bone defect model dogs. J Vet Sci 2008;9:387-93
20. Biazar E, Heidari S, Rezaei-Tavirani M, Jahandideh R. Bone formation in calvarial defects by injectable nanoparticular scaffold loaded with stem cells. Expert Opin Biol Ther 2013;13(12):1653-62
21. Heidari S, Rezaei-Tavirani M, Biazar E,et al. Reconstructing calvarial bone lesions using PHBV scaffolds and cord blood mesenchymal stem cells in rat. J Kermanshah Univ Med Sci 2013;16(8):600-9
22. Emrani H, Davies JE. Umbilical cord perivascular cells: a mesenchymal cell source for treatment of tendon injuries. Open Tissue Eng Regen Med J 2011;4:112-19
23. Greish S, Abogresha N, Abdel-Hady Z,et al. Human umbilical cord mesenchymal stem cells as treatment of adjuvant rheumatoid arthritis in a rat model. World J Stem Cells 2012;26:101-9
24. Liu Y, Mu R, Wang S,et al. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther 2010;12:210-26
25. Arthur A, Zannettino A, Gronthos S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol 2009;218: 237-45
26. Chen WC, Yao CL, Chu IM, Wei YH. Compare the effects of chondrogenesis by culture of human mesenchymal stem cellswith various type of the chondroitin sulfate C. J Biosci Bioeng 2011;111: 226-31
27. Cortes-Morichetti M, Frati G, Schussler O,et al. Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng 2007;13:2681-7
28. Henning RJ, Abu-Ali H, Balis JU,et al. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant 2004;13(7-8):729-39
29. Hu CH, Li ZM, Du ZM,et al. Expanded human cord blood-derived endothelial progenitor cells salvage infarcted myocardium in rats with acute myocardial infarction. Clin Exp Pharmacol Physiol 2010;37:551-6
30. Ma N, Ladilov Y, Kaminski A,et al. Umbilical cord blood cell transplantation for myocardial regeneration. Transplant Proc 2006;38:771-3
31. Kim BO, Tian H, Prasongsukarn K,et al. Cell transplantation improves ventricular functions after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 2005;112:96-104
32. Hirata Y, Sata M, Motomura N,et al. Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem Biophys Res Commun 2005;327:609-14
33. Ghodsizad A, Niehaus M, Kogler G,et al. Transplanted human cord bloodderived unrestricted somatic stem cells improve left-ventricular function and prevent left-ventricular dilation and scar formation after acute myocardial infarction. Heart 2009;95(1):27-35
34. Ghodsizad A, Ungerer MN, Bordel V,et al. Transplanted human cord bloodderived unrestricted somatic stem cells preserve high-energy reserves at the site of acute myocardial infarction. Cytotherapy 2011;13(8):956-61
35. Weiss ML. Whartons jelly or bone marrow mesenchymal stromal cells improved cardiac fuvction following myocardial infraction for more than 32 weeks in a rat model: a preliminary. Curr Stem Cell Res Ther 2013;8(1):46-59
36. Schmidt D, Mol A, Neuenschwander S,et al. Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells. Eur J Cardiothorac Surg 2005;27:795-800
37. Schmidt D, Mol A, Odermatt B,et al. Engineering of biologically active living heart valve leaflets using human umbilical cordderived progenitor cells. Tissue Eng 2006;12:3223-32
38. Semenov O, Breymann C. Mesenchymal stem cells derived from Whartons jelly and their potential for cardio-vascular tissue engineering. Open Tissue Eng Regen Med J 2011;4:64-71
39. Kenar H, Kose GT, Toner M,et al. A 3D aligned microfibrous myocardial tissue construct cultured under transient perfusion. Biomaterials 2011;32:5320-9
40. Turner CG, Fauza DO. Fetal tissue engineering. Clin Perinatol 2009;36:473-88
41. Sodian R, Schaefermeier P, Abegg-Zips S,et al. Use of human umbilical cord blood-derived progenitor cells for tissue-engineered heart valves. Ann Thorac Surg 2010;89(3):819-28
42. Kadner A, Zund G, Maurus C,et al. Human umbilical cord cells for cardiovascular tissue engineering: a comparative study. Eur J Cardiothorac Surg 2004;25(4):635-41
43. Schmidt D, Asmis Lars M, Odermatt B,et al. Engineered living blood vessels: functional endothelia generated from human umbilical cord-derived progenitors. Ann Thorac Surg 2006;82:1465-71
44. Kim SW, Han H, Chae GT,et al. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buergers disease and ischemic limb disease animal model. Stem Cells 2006;24:1620-6
45. Nichols JC, He X, Harris DT. Differentiation of cord blood stem cells into corneal epithelium. Invest Ophthalmol Vis Sci 2005;46:4772-9
46. Harris DT, He X, Badowski M, Nichols JC. Regenerative medicine of the eye: a short review. In: Levicar N, Habib NA, Dimarakis I, Gordon MY, editors, Stem cell repair & regeneration. Volume 3. Imperial College Press, London; 2008. p. 211-55
47. Ma Y, Xu Y, Xiao Z,et al. Reconstruction of chemically burned rat corneal surface by bone marrow derived human mesenchymal stem cells. Stem Cells 2005;24:315-21
48. Yoon KC, You IC, Im SK,et al. Application of umbilical cord serum eyedrops or the treatment neurortrophic keratitis. Ophthalmology 2007;114:1637-42
49. Sharma N, Goel M, VelpandianT,et al. Evaluation of umbilical cord serum therapy in acute ocular chemical burns. Invest Ophthalmol Vis Sci 2011;52(2):1087-92
50. Oh HJ, Jang JY, Li Z,et al. Effects of umbilical cord serum eye drops in a mouse model of ocular chemical. Burn 2012;37(12):1084-90
51. Karamichos D, Rich CB, Hutcheon AEK,et al. Self-assembled matrix by umbilical cord stem cells. J Funct Biomater 2011;2:213-29
52. Joyce NC, Harris DL, Markov V,et al. Potential of human umbilical cord blood mesenchymal stem cells to heal damaged corneal endothelium. Mol Vis 2012;18:547-64
53. Zickri MB, Ahmad NA, Maadawi ZM,et al. Effect of stem cell therapy on induced diabetic keratopathy in albino rat. Int J Stem Cells 2012;5(1):59-66
54. Wakao S, Hayashi T, Kitada M,et al. Long-term observation of auto-cell transplantation in non-human primate reveals safety and efficiency of bone marrow stromal cell-derived Schwann cells in peripheral nerve regeneration. Exp Neurol 2010;223(2):537-47
55. Rosenkranz K, Kumbruch S, Tenbusch M,et al. Transplantation of human umbilical cord blood cells mediated beneficial effects on apoptosis, angiogenesis and neuronal survival after hypoxic-ischemic brain injury in rats. Cell Tissue Res 2012;348(3):429-38
56. Arien-Zakay H, Lecht S, Nagler A, Lazarovici P. Neuroprotection by human umbilical cord blood-derived progenitors in ischemic brain injuries. Arch Ital Biol 2011;149(2):233-45
57. Lim JY, Jeone CH, Jun JA,et al. Therapeutic effects of human umbilical cord blood derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Res Ther 2011;2:38-51
58. Bachstetter D, Pabon M, Cole J,et al. Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain. BMC Neurosci 2008;9(22):1-9
59. Meier C, Middelanis J, Wasielewski B,et al. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res 2006;59:244-9
60. Sobani ZA, Quadri SA, Enam SA. Stem cells for spinal cord regeneration: current status. Surg Neurol Int 2010;25(1):93-108
61. Yan-Wu G, Yi-Quan K, Ming L,et al. Human umbilical cord-derived schwannlike cell transplantation combined with neurotrophin-3 administration in dyskinesia of rats with spinal cord injury. Neurochem Res 2011;36(5):783-92
62. Carvalho MM, Teixeira FG, Reis RL,et al. Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine. Curr Stem Cell Res Ther 2011;6(3):221-8
63. Kang KS, Kim SW, Oh YH,et al. Thirty-seven year old spinal cord-injured female patient, tranplanted of multipotent stem cells from human UC blood with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy 2005;7:368-73
64. Zhilaia Z, Huia Z, Anmina J,et al. A combination of taxol infusion and human umbilical cord mesenchymal stem cells transplantation for the treatment of rat spinal cord injury. Brain Res 2012;1481:79-89
65. Koh SH, Kim KS, Choi MR,et al. Implantation of human umbilical cordderived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res 2008;1229:233-48
66. Ding DC, Shyu WC, Chiang MF,et al. Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol Dis 2007;27:339-53
67. Garbuzova-Davis S, Willing AE, ZigovaT,et al. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res 2003; 12(3):255-70
68. Sanberg PR, Willing AE, Garbuzova-Davis S,et al. Umbilical cord blood-derived stem cells and brain repair. Ann NY Acad Sci 2005;1049:67-83
69. Garbuzova-Davis S, Sanberg-Davis C, Kuzmin-Nichols N,et al. Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS One 2008;3(6):e2494
70. Xiong N, Zhang Z, Huang J,et al. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinsons disease. Gene Ther 2010;18:394-402
71. Li M, Zhang SZ, Guo YW,et al. Human umbilical veinderived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinsons disease. Neurochem Res 2010;35(10):1522-9
72. Weiss ML, Medicetty S, Bledsoe AR,et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinsons disease. Stem Cells 2006;24(3):781-92
73. Lee HJ, Lee JK, Lee H,et al. Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimers disease mouse model through modulation of neuroinflammation. Neurobiol Aging 2012;33:588-602
74. Kim JY, Kim DH, Kim JH,et al. Umbilical cord blood mesenchymal stem cells protect amyloid-beta42 neurotoxicity via paracrine. World J Stem Cells 2012;26:110-16. Available from: http://clinicaltrials.gov/2012
75. Ruetze M, Gallinat S, Lim IJ,et al. Common features of umbilical cord epithelial cells and epidermal keratinocytes. J Dermatol Sci 2008;50:227-31
76. Dai Y, Li J, Li J,et al. Skin epithelial cells in mice from umbilical cord blood mesenchymal stem cells. Burns 2007;33(4):418-28
77. Leng X, Zhang Q, Zhai X, Chen Z. Local transplant of human umbilical cord matrix stem cells improves skin flap survival in a mouse model. Tohoku J Exp Med 2012;227:191-7
78. Azari O, Babaei H, Derakhshanfar A,et al. Effects of transplanted mesenchymal stem cells isolated from Whartons jelly of caprine umbilical cord on cutaneous wound healing; histopathological evaluation. Vet Res Commun 2011;35(4):211-22
79. Zhang Y, Hao H, Liu J,et al. Repair and regeneration of skin injury by transplanting microparticles mixed with Whartons jelly and MSCs from the human umbilical cord. Int J Low Extrem Wounds 2012;11(4):264-70
80. Yoo BY, Shin YH, Yoon HH,et al. Evaluation of human umbilical cordderived mesenchymal stem cells on in vivo hair inducing activity. TERM 2009;6(1):15-22
81. Zebardast N, Lickorish D, Davies JE. Human umbilical cord perivascular cells (HUCPVC): a mesenchymal cell source for dermal wound healing. Organogenesis 2010;6:197-203
82. Liao Y, Itoh M, Yang A,et al. Human cord blood derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa. Cell Transplant 2013; In press
83. Biazar E, Heidari S, Tavirani M,et al. The healing effect of human unrestricted somatic stem cells loaded in collagenmodified nanofibrous PHBV scaffold on full-thickness skin defects. Artif Cell Tissue Reg 2013; In press
84. Biazar E, Heidari S. The healing effect of stem cells loaded in nanofibrous scaffolds on full thickness skin defects. J Biomed Nanotechnol 2013;9:1471-82
85. Zeinali R, Biazar E, Heidari S,et al. Regeneration of full-thickness skin defects using umbilical cord stem cells loaded into modified porous scaffolds. ASAIO J 2014;60(1):106-14
86. Ende N, Chen R, Reddi AS. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun 2004;325:665-9
87. Ende N, Chen R, Reddi AS. Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in type 2 diabetic mice. Biochem Biophys Res Commun 2004;321:168-71
88. Haller MJ, Wasserfall CH, McGrail KM,et al. Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care 2009;32:2041-6
89. Shi LL, Liu FP, Wang DW. Transplantation of human umbilical cord blood mesenchymal stem cells improves survival rates in a rat model of acute hepatic necrosis. Am J Med Sci 2011;342(3):212-17
90. Ghodsizad A, Fahy BN, Waclawczyk S,et al. Portal application of human unrestricted somatic stem cells to support hepatic regeneration after portal embolization and tumor surgery. ASAIO J 2012;58(3):255-61
91. Haller MJ, Viener HL, Wasserfall C,et al. Autologous umbilical cord blood transfusion for type 1 diabetes. Exp Hematol 2008;36:710-15
92. Chang JW, Hung SP, Wu HH,et al. Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transplant 2011;20(2): 245-57
93. Sun L, Wang D, Liang J,et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 2010;62:2467-75
94. Chang YS, Oh W, Choi SJ,et al. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplant 2009;18(8):869-86
95. Sueblinvong V, Loi R, Eisenhauer PL,et al. Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. Am J Respir Crit Care Med 2008;177:701-11
96. Tu HY, Wu BQ, Chen L,et al. Protective effects of human umbilical cord mesenchymal stem cells on lung fibrosis in newborn rats. Chin J Tissue Eng Res 2012;16(19):3482-5
97. Ayuzawa R, Doi C, Rachakatla RS,et al. Naive human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer Lett 2009;280:31-7
98. Revoltella RP, Papini S, Rosellini A,et al. Covhlear repair by transplantation of human cord blood CD133+ cells to nod-scid mice made deaf with kanamycin and noise. Cell Transplant 2008;17(6): 665-78